Description
Tagrisso price
Tagrisso (osimertinib) may be used to treat adults with non-small cell lung cancer (NSCLC) whose tumors have certain abnormal epidermal growth factor receptor (EGFR) gene(s). Tagrisso is used: tagrisso price
- to help prevent your lung cancer from coming back after you have had surgery to remove your tumor(s)
- when your lung cancer has spread to nearby tissues (locally advanced) and is unable to be
removed (unresectable) by surgery and has responded or stabilized following chemotherapy and
radiation treatment - as your first treatment when your lung cancer has spread to other parts of the body (metastatic)
- in combination with pemetrexed and platinum-based chemotherapy, as your first treatment when
your lung cancer is locally advanced or metastasized - when your lung cancer has metastasized, and you have had previous treatment with an EGFR tyrosine kinase inhibitor (TKI) medicine that did not work or is no longer working.
Your healthcare provider will perform a test to make sure that Tagrisso is right for you. See What is Tagrisso used for, for more information.
Tagrisso’s mechanism of action involves targeting the EGFR receptor, specifically the T790M mutation that blocks the signaling of EGFR which suppresses cell growth and induces programmed cell death in cancer cells with these specific mutations. Tagrisso is a targeted treatment and is not chemotherapy. tagrisso price
Tagrisso first gained FDA approval on November 13, 2015. Tagrisso belongs to the drug class tyrosine kinase inhibitors (TKI). See the Tagrisso Prescribing Information for more information.
Reviews
There are no reviews yet.